Pyoderma gangrenosum treated with cyclosporin A
- 1 November 1985
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 113 (5) , 601-604
- https://doi.org/10.1111/j.1365-2133.1985.tb02385.x
Abstract
A 49-year-old woman with a 14-year history of pyoderma gangrenosum unresponsive to a variety of systemic and topical treatments was given oral cyclosporin A (CyA), a potent immunosuppressive agent widely used in organ transplantation for the prophylaxis of acute graft-versus-host disease. Improvement and subsequent healing of the lesions was evident within 3 weeks of starting treatment and has continued for the duration of treatment (12 months).Keywords
This publication has 5 references indexed in Scilit:
- Side effects of systemic cyclosporine in patients not undergoing transplantationThe American Journal of Medicine, 1984
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host diseaseBritish Journal of Dermatology, 1984
- T Helper-suppressor Cell Imbalance in Pyoderma Gangrenosum, with Relapsing Polychondritis and Corneal KeratolysisAmerican Journal of Clinical Pathology, 1983
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979